Profile
Valerie Morisset is the founder.
Dr. Morisset was the founder of Climb Bio, Inc. (2018) as Chief Scientific Officer, EVP & Head-R&D.
Dr. Morisset was also the founder of Convergence Pharmaceuticals Ltd. Dr. Morisset is currently the Director at Eliem Therapeutics (UK) Ltd. since 2019.
Former jobs include Principal at GlaxoSmithKline LLC and Venture Partner at Bridge Valley Ventures LLP (2018-2019).
Education includes a graduate degree from Université de Bordeaux.
Valerie Morisset active positions
| Companies | Position | Start |
|---|---|---|
Eliem Therapeutics (UK) Ltd.
Eliem Therapeutics (UK) Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Director/Board Member | 2019-12-17 |
Former positions of Valerie Morisset
| Companies | Position | End |
|---|---|---|
| CLIMB BIO, INC. | Founder | 2024-08-22 |
Bridge Valley Ventures LLP
Bridge Valley Ventures LLP Investment ManagersFinance Bridge Valley Ventures invests in companies located in the UK, Europe and North America. The firm focuses on oncology, neuroscience, immunology and rare diseases therapeutics, pharma/biotech sector. They provide financing for buyout transaction. | Corporate Officer/Principal | 2019-02-28 |
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops neuropathic pain products | Founder | 2017-12-31 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
Training of Valerie Morisset
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Université de Bordeaux
Université de Bordeaux Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops neuropathic pain products | Health Technology |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Bridge Valley Ventures LLP
Bridge Valley Ventures LLP Investment ManagersFinance Bridge Valley Ventures invests in companies located in the UK, Europe and North America. The firm focuses on oncology, neuroscience, immunology and rare diseases therapeutics, pharma/biotech sector. They provide financing for buyout transaction. | Finance |
Eliem Therapeutics (UK) Ltd.
Eliem Therapeutics (UK) Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Health Technology |
- Stock Market
- Insiders
- Valerie Morisset
















